Dose-dependent inhibition of myointimal hyperplasia by orally administered rapamycin

Annals of Vascular Surgery
Norio UchimuraIan L Gordon

Abstract

Myointimal hyperplasia (MIH) after vascular intervention is a major problem. Recent reports describing elimination of within-stent restenosis by means of rapamycin-eluting stents prompted us to examine the effect of systemic oral rapamycin on MIH induced by arterial trauma. We studied the effect of oral rapamycin on MIH after rabbit aorta balloon injury. Thirty-five New Zealand white rabbits (2.5-3 kg) had aortic injury and were given either no rapamycin (control), 0.1 (low dose) rapamycin mg/kg/day, or 0.4 mg/kg/day (high dose). Rapamycin was started 1 week before injury and continued for 3 (4 weeks total) or 6 weeks (7 weeks total) post-injury. Sections were analyzed to measure aortic intima/media area ratios (I:M) at either 3 or 6 weeks. At 3 weeks, the I:M (mean +/- SD) for controls was 0.53 +/- 0.1; for low dose, 0.17 +/- 0.13; and for high dose, 0.24 +/- 0.07 (p < 0.001 vs. control). At 6 weeks, the I:M for controls was 0.52 +/- 0.12; for low dose-4 weeks, 0.29 +/- 0.15; low dose-7 weeks, 0.33 +/- 0.07; and high dose-4 weeks, 0.47 +/- 0.16. At 6 weeks only the difference between the low dose-4 weeks and control I:M ratios was significant (p = 0.018). The results confirm earlier studies showing that systemic rapamycin inhi...Continue Reading

References

Mar 1, 1993·Clinical and Experimental Rheumatology·R P CarlsonA J Lewis
Jun 23, 1993·Annals of the New York Academy of Sciences·P S AlmondA Matas
Jan 1, 1993·European Journal of Vascular Surgery·R D SayersN J London
Dec 1, 1995·Therapeutic Drug Monitoring·R W YatscoffJ Zimmerman
Jun 1, 1996·Current Opinion in Immunology·R T Abraham
Nov 15, 1996·The Journal of Clinical Investigation·M PoonA R Marks
Apr 29, 1998·The American Journal of Cardiology·R S Schwartz
Jan 13, 1999·Circulation·A FarbR Virmani
Jun 15, 1999·Journal of Cardiovascular Pharmacology·S E BurkeC D Wegner
Jan 15, 2000·Journal of the American College of Cardiology·P H GreweK M Müller
Oct 10, 2001·Therapeutic Drug Monitoring·K L Napoli, P J Taylor
Jan 5, 2002·British Medical Bulletin·E RegarP W Serruys
Jul 12, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ali MoustaphaH Vernon Anderson
Jul 20, 2002·Coronary Artery Disease·Bruce D KlugherzRobert L Wilensky
Oct 31, 2002·Circulation·Andrew FarbRenu Virmani

❮ Previous
Next ❯

Citations

Feb 19, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·David D KimWalter N Durán
Jun 10, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Thomas JahnkeStefan Müller-Hülsbeck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.